Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells
2016 · Cell Reports · 66 citations
https://doi.org/10.1016/j.celrep.2016.05.087
A
Anna Wurtz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
198
Papers
2.5K
Citations
15
h-index
17
i10-index
Anna Wurtz is an academic researcher from Yale Cancer Center. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & RNA modifications and cancer & Cytokine Signaling Pathways and Interactions. The author has an h-index of 15, co-authored 169 publications.
Papers by this author
worksCo-Occurring Alterations in Multiple Tumor Suppressor Genes Are Associated With Worse Outcomes in Patients With EGFR-Mutant Lung Cancer
2023 · Journal of Thoracic Oncology · 56 citations
https://doi.org/10.1016/j.jtho.2023.10.001
ASCL1 Drives Tolerance to Osimertinib in <i>EGFR</i> Mutant Lung Cancer in Permissive Cellular Contexts
2024 · Cancer Research · 24 citations
https://doi.org/10.1158/0008-5472.can-23-0438
Figure S4 from ASCL1 Drives Tolerance to Osimertinib in <i>EGFR</i> Mutant Lung Cancer in Permissive Cellular Contexts
2024 · 0 citations
https://doi.org/10.1158/0008-5472.25607394
Table S2 from ASCL1 Drives Tolerance to Osimertinib in <i>EGFR</i> Mutant Lung Cancer in Permissive Cellular Contexts
2024 · 0 citations
https://doi.org/10.1158/0008-5472.25607376
Figure S6 from ASCL1 Drives Tolerance to Osimertinib in <i>EGFR</i> Mutant Lung Cancer in Permissive Cellular Contexts
2024 · 0 citations
https://doi.org/10.1158/0008-5472.25607388.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat